Double-Positive Anti-GBM/ANCA — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Plasma exchange, cyclophosphamide and glucocorticoids
Double-positive disease (ANCA + anti-GBM) occurs in approximately 5-10% of anti-GBM cases. KDIGO 2024 AAV guideline practice point 9.3.1.10 states: add plasma exchange for patients with overlap syndrome of ANCA-associated vasculitis and anti-GBM disease. The treatment should follow the anti-GBM protocol (plasma exchange + cyclophosphamide + glucocorticoids) given the severity and the presence of anti-GBM antibodies, which mediate the most acute injury.
Reference: https://guidelines.ukkidney.org